Company: IXHL
Filing Date: 2025-04-16
Form Type: S-1/A
Source: 0001213900-25-032577
Chunk: 4

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-16
Form: S-1/A
Chunk 4
---
260.5% of the 27,546,753 shares of our Common Stock outstanding as of April 11, 2025 and 92.19% of our total shares of Common Stock outstanding assuming the exercise of all Pre-Funded Warrants and the issuance of the maximum number of shares of Common Stock that may be issuable upon exercise of the Series A Warrants. Given the substantial number of shares being registered for potential resale by the selling stockholders pursuant to this prospectus, whether as a result of substantial sales of our Common Stock by the selling stockholders or the perception in the market that holders of a large number of selling stockholders intend to sell their shares, the market price of shares of our Common Stock could decline significantly and the volatility of the market price of our Common Stock could increase significantly, even if our research and development efforts are going well. See “Risk Factors”beginning on page 6 of this prospectus for more information.

Our Common Stock is traded
on The Nasdaq Global Market under the symbol “IXHL.” On April 11, 2025, the closing sale price of the Common Stock on Nasdaq
was $0.629 per share.

We are an emerging growth company and a smaller reporting company under the federal securities laws and, as such, are subject to certain reduced public company reporting requirements. See “ Prospectus Summary - Implications of Being an Emerging Growth Company and a Smaller Reporting Company” on page 4 of this prospectus.

Investing in our Common Stock involves a high degree of risk. Please consider carefully the risks described in this prospectus under “Risk Factors” beginning on page 6 of this prospectus and in our filings with the Securities and Exchange Commission.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is ________, 2025

TABLE OF CONTENTS</div>

| ABOUT THIS PROSPECTUS                              |     | ii |
| PROSPECTUS SUMMARY                                 |     |  1 |
| THE OFFERING                                       |     |  5 |
| RISK FACTORS                                       |     |  6 |
| SPECIAL NOTE REGARDING FORWARD-LOOKING INFORMATION |     |  8 |
| dIVIDEND POLICY                                    |     | 11 |
| USE OF PROCEEDS                                    |     | 10 |